Connect with us
Researchers at McMaster University identified the uPAR receptor as a key marker in glioblastoma tumor-initiating cells. Published in Science Translational Medicine, their study showed that targeting...
Novo Nordisk has transferred its discontinued Parkinson’s therapy to AI biotech startup Cellular Intelligence, retaining equity and milestone rights instead of making a traditional sale. The...
IgA nephropathy, a rare autoimmune disease often leading to kidney failure, previously lacked targeted treatments, relying on supportive care with limited effectiveness. The new drug esparsentan...
The inflammatory bowel disease market is rapidly growing, driven by unmet patient needs despite existing therapies. Major pharma acquisitions highlight strong demand for innovative treatments. Abivax’s...
Biotech news this week highlights sharp contrasts: Redcare Pharmacy posted strong growth and profitability, while Ocugen faced rising costs despite higher revenue but secured $115 million...
At Swiss Biotech Day in Basel, early discussions lacked data, revealing mixed sentiment despite official reports showing strong growth. Switzerland’s biotech sector reached record revenues, stable...
Johnson & Johnson has EU approval for nipocalimab for generalized myasthenia gravis, showing superior control and sustained benefits. Sanofi reported a safer protein COVID-19 vaccine versus...
Johnson & Johnson announced a new investment as part of its $55 billion US expansion, including a Montgomery County biomanufacturing site creating 500 permanent jobs and...
Onyx Biotech has raised pre-seed funding from Life Science Valley Growth Fund, Freiraum Ventures, and business angels to advance AI-driven drug development. Founded in 2024, the...
BB Biotech actively restructured its portfolio in early 2026, adding eleven stocks and expanding investment guidelines. Its share price outperformed net asset value, narrowing the valuation...